Swiss pharma giant Roche today announced the opening of the new pharmaceutical research and development center at its global ...

Roche's experimental weight-loss pill, CT-996, showed promising early-stage trial results, causing shares to rise. However, ...

Roche started the termination process last year ... buoyed by a 2022 approval for all RET-positive tumours, regardless of their location in the body. Take-up of both products has been pegged ...

Lunit’s AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche’s navify® Digital Pathology platform to enhance ...

A contract for consigning clothes goes south for local customers. Those customers include a non- profit which lost thousands ...

Books will be held year-round at the Creston News Advertiser and can be accessed through the CNA side entrance on Division ...

Rich nations hold millions of mpox vaccines as Africa grapples with an outbreak, while the US FDA approves Roche's multiple ...

Xofluza was well tolerated with no new safety signals identified. Every year, seasonal influenza infects an estimated one billion people and causes up to 650,000 deaths globally. On Thursday ...

Significant control over Roche Holding by retail investors implies that the general public has more power to influence management and governance-related decisions A total of 25 investors have a ...

Darragh Roche is a U.S. News Reporter based in Limerick, Ireland. His focus is reporting on U.S. politics. He has covered the Biden administration, election polling and the U.S. Supreme Court.

“Pune is the only site for Roche worldwide, where it is a co-location for so many functions,” says Raja Jamalamadaka, Managing Director of Roche Information Solutions India. Roche Information ...